BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15795089)

  • 41. Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs.
    Huisman MT; Smit JW; Crommentuyn KM; Zelcer N; Wiltshire HR; Beijnen JH; Schinkel AH
    AIDS; 2002 Nov; 16(17):2295-301. PubMed ID: 12441801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters.
    Leslie EM; Deeley RG; Cole SP
    Toxicology; 2001 Oct; 167(1):3-23. PubMed ID: 11557126
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular basis for reduced estrone sulfate transport and altered modulator sensitivity of transmembrane helix (TM) 6 and TM17 mutants of multidrug resistance protein 1 (ABCC1).
    Maeno K; Nakajima A; Conseil G; Rothnie A; Deeley RG; Cole SP
    Drug Metab Dispos; 2009 Jul; 37(7):1411-20. PubMed ID: 19398503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP.
    Xiao L; Yi T; Chen M; Lam CW; Zhou H
    Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the binding of the tricyclic isoxazole photoaffinity label LY475776 to multidrug resistance associated protein 1 (MRP1) orthologs and several ATP- binding cassette (ABC) drug transporters.
    Dantzig AH; Shepard RL; Pratt SE; Tabas LB; Lander PA; Ma L; Paul DC; Williams DC; Peng SB; Slapak CA; Godinot N; Perry WL
    Biochem Pharmacol; 2004 Mar; 67(6):1111-21. PubMed ID: 15006547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport.
    Ito K; Olsen SL; Qiu W; Deeley RG; Cole SP
    J Biol Chem; 2001 May; 276(19):15616-24. PubMed ID: 11278867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulators of multidrug resistance associated proteins in the management of anticancer and antimicrobial drug resistance and the treatment of inflammatory diseases.
    Yang AK; Zhou ZW; Wei MQ; Liu JP; Zhou SF
    Curr Top Med Chem; 2010; 10(17):1732-56. PubMed ID: 20645920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein.
    Matsushima S; Maeda K; Kondo C; Hirano M; Sasaki M; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1059-67. PubMed ID: 15901800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of members of the multidrug resistance protein family in human term placenta.
    St-Pierre MV; Serrano MA; Macias RI; Dubs U; Hoechli M; Lauper U; Meier PJ; Marin JJ
    Am J Physiol Regul Integr Comp Physiol; 2000 Oct; 279(4):R1495-503. PubMed ID: 11004020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of the role of polar amino acid residues within predicted transmembrane helix 17 in determining the substrate specificity of multidrug resistance protein 3.
    Zhang DW; Gu HM; Vasa M; Muredda M; Cole SP; Deeley RG
    Biochemistry; 2003 Aug; 42(33):9989-10000. PubMed ID: 12924948
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors.
    Weiss J; Theile D; Ketabi-Kiyanvash N; Lindenmaier H; Haefeli WE
    Drug Metab Dispos; 2007 Mar; 35(3):340-4. PubMed ID: 17172311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver.
    Shoda J; Miura T; Utsunomiya H; Oda K; Yamamoto M; Kano M; Ikegami T; Tanaka N; Akita H; Ito K; Suzuki H; Sugiyama Y
    Hepatology; 2004 Jan; 39(1):167-78. PubMed ID: 14752835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy.
    Keppler D
    Handb Exp Pharmacol; 2011; (201):299-323. PubMed ID: 21103974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A family of drug transporters: the multidrug resistance-associated proteins.
    Borst P; Evers R; Kool M; Wijnholds J
    J Natl Cancer Inst; 2000 Aug; 92(16):1295-302. PubMed ID: 10944550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multidrug resistance-associated proteins: Export pumps for conjugates with glutathione, glucuronate or sulfate.
    Homolya L; VĂ¡radi A; Sarkadi B
    Biofactors; 2003; 17(1-4):103-14. PubMed ID: 12897433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport.
    Zeng H; Chen ZS; Belinsky MG; Rea PA; Kruh GD
    Cancer Res; 2001 Oct; 61(19):7225-32. PubMed ID: 11585759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estradiol 3-glucuronide is transported by the multidrug resistance-associated protein 2 but does not activate the allosteric site bound by estradiol 17-glucuronide.
    Gerk PM; Li W; Vore M
    Drug Metab Dispos; 2004 Oct; 32(10):1139-45. PubMed ID: 15280218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
    Leslie EM; Deeley RG; Cole SP
    Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic clearance of reactive glucuronide metabolites of diclofenac in the mouse is dependent on multiple ATP-binding cassette efflux transporters.
    Lagas JS; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
    Mol Pharmacol; 2010 Apr; 77(4):687-94. PubMed ID: 20086033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glucuronidation as a mechanism of intrinsic drug resistance in colon cancer cells: contribution of drug transport proteins.
    Cummings J; Zelcer N; Allen JD; Yao D; Boyd G; Maliepaard M; Friedberg TH; Smyth JF; Jodrell DI
    Biochem Pharmacol; 2004 Jan; 67(1):31-9. PubMed ID: 14667926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.